Medicare Benefits Schedule - Item 50952

Search Results for Item 50952

View Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

50952

50952 - Additional Information

Item Start Date:
01-May-2004
Description Updated:
01-Jul-2021
Schedule Fee Updated:
01-Jul-2024

Group
T8 - Surgical Operations
Subgroup
16 - Tissue ablation

Unresectable primary malignant tumour of the liver, destruction of, by open or laparoscopic ablation  (including any associated imaging services), if a multi‑disciplinary team has assessed that percutaneous ablation cannot be performed or is not practical because of one or more of the following clinical circumstances:
(a) percutaneous access cannot be achieved;
(b) vital organs or tissues are at risk of damage from the percutaneous ablation procedure;
(c) resection of one part of the liver is possible, however there is at least one primary liver tumour in an unresectable portion of the liver that is suitable for ablation;
other than a service associated with a service to which item 30419 or 50950 applies

 

Multiple Operation Rule

(Anaes.)

Fee: $930.85 Benefit: 75% = $698.15 85% = $828.45

(See para TN.8.120 of explanatory notes to this Category)


Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

TN.8.120

Unresectable primary malignant tumour of the liver destruction of by open or laparoscopic ablation (Item 50952)

A multi-disciplinary team for the purposes of item 50952 would include a hepatobilliary surgeon, interventional radiologist and a gastroenterologist or oncologist.

 

Related Items: 50952


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change